Neumonía por Pneumocystis jiroveci post inicio de tratamiento con infliximab en paciente con enfermedad de Crohn / Pneumocystis jiroveci pneumonia following infliximab therapy in patient with Crohn's disease
Rev. chil. infectol
; 34(5): 518-519, oct. 2017. graf
Article
in Spanish
| LILACS
| ID: biblio-1042641
Responsible library:
CL1.1
ABSTRACT
There are no evidence-based guidelines about prophylaxis against Pneumocystis jiroveci pneumonia in inflammatory bowel disease. We report a case of P. jiroveci pneumonia in patient with Crohn's disease receiving infliximab and methotrexate. This case emphasizes the importance of considering the possibility of this infection in inflammatory bowel disease patients treated on biological therapy.
Full text:
Available
Collection:
International databases
Database:
LILACS
Main subject:
Pneumonia, Pneumocystis
/
Gastrointestinal Agents
/
Crohn Disease
/
Infliximab
Type of study:
Diagnostic study
/
Etiology study
/
Practice guideline
Limits:
Female
/
Humans
Language:
Spanish
Journal:
Rev. chil. infectol
Journal subject:
Communicable Diseases
Year:
2017
Document type:
Article
Affiliation country:
Chile
Institution/Affiliation country:
Clínica Las Condes/CL